Experimental treatment significantly slows progression of a fatal brain disease in women during clinical trial
Researchers at Tel Aviv University have presented new findings indicating that the experimental drug Davunetide may significantly slow the progression of progressive supranuclear palsy (PSP) in women, ...
2 Aug 21:00 · Medical Xpress